It could be inferred from the large percentage of amplification and mRNA high among all mutation types that the upregulation of ACP6 in HCC might be attributed to genetic alterations such as amplification and mRNA high occurring in the genome of ACP6. This evidence concerns the gene ACP6 and hepatocellular carcinoma.